Session Chair Profile
Founder & CEO, 2bPrecise
Assaf Halevy, Founder & CEO of 2bPrecise, brings extensive experience and deep insight into the development of emerging healthcare technologies. He leads a select team focused on assessing market potential of genomics and precision medicine solutions that promise to impact care delivery and patient outcomes. Assaf joined Allscripts in 2013 as SVP of Business Development when the company acquired dbMotion, the foremost clinical integration/population health management platform in the industry today.
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: While Precision Medicine is starting to deliver on some of its promise, hurdles still remain. Viewing interpreted genomic data within the context of a patient’s clinical record is challenging enough, but how do we add meaningful information into the existing workflow to inform a provider when a genetic test makes sense for their patient? And how do we make it easy to ingest the interpreted results to lead to better informed treatment decisions? In this session we will hear from a panel of industry leaders on the clinical, technical, organizational and political barriers that exist in the clinical enablement of precision medicine.